Early prophylactic rituximab reduces EBV infection and PTLD in high-risk patients receiving allogeneic hematopoietic stem cell transplantation.

Zhang A, Zhang Z, Bian H, Man Z, Zhang S, Jiang C, Wang L, Huang J, Pan Z, Lu H, Chen C, Zhao WL, Lin R, Cao Y, Hu X.

DOI: 10.1016/j.jtct.2026.09.035
Published: 2026-09-21
Container: Transplant Cell Ther
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jtct.2026.09.035,
  title = {Early prophylactic rituximab reduces EBV infection and PTLD in high-risk patients receiving allogeneic hematopoietic stem cell transplantation.},
  author = {Zhang A and  Zhang Z and  Bian H and  Man Z and  Zhang S and  Jiang C and  Wang L and  Huang J and  Pan Z and  Lu H and  Chen C and  Zhao WL and  Lin R and  Cao Y and  Hu X.},
  year = {2026},
  journal = {Transplant Cell Ther},
  doi = {10.1016/j.jtct.2026.09.035},
  url = {https://doi.org/10.1016/j.jtct.2026.09.035}
}

RIS

TY  - JOUR
TI  - Early prophylactic rituximab reduces EBV infection and PTLD in high-risk patients receiving allogeneic hematopoietic stem cell transplantation.
AU  - Zhang A
AU  -  Zhang Z
AU  -  Bian H
AU  -  Man Z
AU  -  Zhang S
AU  -  Jiang C
AU  -  Wang L
AU  -  Huang J
AU  -  Pan Z
AU  -  Lu H
AU  -  Chen C
AU  -  Zhao WL
AU  -  Lin R
AU  -  Cao Y
AU  -  Hu X.
PY  - 2026
JO  - Transplant Cell Ther
DO  - 10.1016/j.jtct.2026.09.035
UR  - https://doi.org/10.1016/j.jtct.2026.09.035
ER  -

APA

A, Z., Z, Z., H, B., Z, M., S, Z., C, J., L, W., J, H., Z, P., H, L., C, C., WL, Z., R, L., Y, C., & X., H. (2026). Early prophylactic rituximab reduces EBV infection and PTLD in high-risk patients receiving allogeneic hematopoietic stem cell transplantation.. Transplant Cell Ther. https://doi.org/10.1016/j.jtct.2026.09.035

Source records

europe-pmc · retrieved 2026-09-25T19:35:53.843Z